• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌患者的非癌症死亡率风险较高:来自 SEER-Medicaid 的证据。

High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.

机构信息

Department of Urology, The ChenJiaqiao Hospital of ShaPingba District of Chongqing City, Chongqing, 401331, People's Republic of China.

Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, No.76, Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.

出版信息

J Cancer Res Clin Oncol. 2023 Sep;149(12):10203-10215. doi: 10.1007/s00432-023-04867-z. Epub 2023 Jun 3.

DOI:10.1007/s00432-023-04867-z
PMID:37270459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10423154/
Abstract

PURPOSE

The objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis.

METHODS

Eligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (SMRs). The proportions of different non-cancer cause of death were calculated and analyzed in different follow-up periods. Multivariate competing risk model was used to analyze the risk factors for death of BC and non-cancer diseases.

RESULTS

In total, 240,954 BC patients were included and 106,092 patients experienced death, with 37,205 (35.07%), 13,208 (12.45%) and 55,679 (52.48%) patients experienced BC, other cancer and non-cancer disease-related deaths, respectively. Overall SMR for BC patients who died from non-cancer diseases was 2.42 (95% CI [2.40-2.44]). Cardiovascular diseases were the most common non-cancer cause of death, followed by respiratory diseases, diabetes mellitus, and infectious diseases. Multivariate competing risk analysis identified the following high-risk factors for non-cancer mortality: age > 60 years, male, whites, in situ stage, pathological type of transitional cell carcinoma, not receiving treatment (including surgery, chemotherapy, or radiation), and widowed.

CONCLUSIONS

Cardiovascular diseases are the leading non-cancer cause of death in BC patients, followed by respiratory disease, diabetes mellitus and infectious diseases. Physicians should pay attention to the risk of death from these non-cancer diseases. Also, physicians should encourage patients to engage in more proactive self-surveillance and follow up.

摘要

目的

本研究旨在探讨膀胱癌(BC)诊断后非癌症死亡的原因和相关危险因素。

方法

从 SEER 数据库中获取符合条件的 BC 患者。使用 SEER*Stat 软件 8.3.9.2 计算标准化死亡率比(SMR)。计算并分析不同随访期不同非癌症死因的比例。多变量竞争风险模型用于分析 BC 和非癌症疾病死亡的危险因素。

结果

共纳入 240954 例 BC 患者,其中 106092 例患者死亡,37205(35.07%)、13208(12.45%)和 55679(52.48%)例患者分别死于 BC、其他癌症和非癌症疾病。死于非癌症疾病的 BC 患者的总体 SMR 为 2.42(95%CI[2.40-2.44])。心血管疾病是非癌症死亡的最常见原因,其次是呼吸疾病、糖尿病和传染病。多变量竞争风险分析确定了非癌症死亡率的以下高危因素:年龄>60 岁、男性、白人、原位期、移行细胞癌的病理类型、未接受治疗(包括手术、化疗或放疗)和丧偶。

结论

心血管疾病是 BC 患者非癌症死亡的主要原因,其次是呼吸疾病、糖尿病和传染病。医生应注意这些非癌症疾病的死亡风险。此外,医生应鼓励患者进行更积极主动的自我监测和随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/24799f1b0e93/432_2023_4867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/cfee9374cff1/432_2023_4867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/ec4d766fd3ba/432_2023_4867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/24799f1b0e93/432_2023_4867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/cfee9374cff1/432_2023_4867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/ec4d766fd3ba/432_2023_4867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdeb/11797335/24799f1b0e93/432_2023_4867_Fig3_HTML.jpg

相似文献

1
High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.膀胱癌患者的非癌症死亡率风险较高:来自 SEER-Medicaid 的证据。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10203-10215. doi: 10.1007/s00432-023-04867-z. Epub 2023 Jun 3.
2
Short-term mortality risks among patients with non-metastatic bladder cancer.非转移性膀胱癌患者的短期死亡风险。
BMC Cancer. 2020 Nov 25;20(1):1148. doi: 10.1186/s12885-020-07655-x.
3
Trends in the cause of death among patients with bladder cancer in the US SEER population, 1992-2018.美国监测、流行病学和最终结果数据库中 1992-2018 年膀胱癌患者死因趋势。
World J Urol. 2022 Jun;40(6):1497-1503. doi: 10.1007/s00345-022-03971-y. Epub 2022 Mar 2.
4
Causes of death after breast cancer diagnosis: A US population-based analysis.乳腺癌诊断后的死因分析:一项基于美国人群的分析。
Cancer. 2020 Apr 1;126(7):1559-1567. doi: 10.1002/cncr.32648. Epub 2019 Dec 16.
5
Non-bladder cancer mortality in patients with urothelial cancer of the bladder.膀胱癌患者中非膀胱癌相关死亡率。
Urol Oncol. 2013 Jul;31(5):656-63. doi: 10.1016/j.urolonc.2011.03.005. Epub 2011 May 7.
6
Chronic Obstructive Pulmonary Disease Mortality in Bladder Cancer Patients: A SEER-Based Competing Risk Analysis.膀胱癌患者慢性阻塞性肺疾病死亡率:基于 SEER 的竞争风险分析。
Urol J. 2024 May 6;21(3):146-154. doi: 10.22037/uj.v20i.7644.
7
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.乳腺癌心血管死亡的竞争风险分析:来自监测、流行病学和最终结果(SEER)数据库的证据
Transl Cancer Res. 2023 Dec 31;12(12):3591-3603. doi: 10.21037/tcr-23-1163. Epub 2023 Dec 8.
8
Immediate risk of non-cancer deaths after a cancer diagnosis.癌症诊断后的非癌症死亡即时风险。
BMC Cancer. 2021 Aug 27;21(1):963. doi: 10.1186/s12885-021-08707-6.
9
Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database.SEER 数据库中膀胱癌患者按种族和性别划分的特定病因死亡率差异。
Cancer Causes Control. 2023 Jun;34(6):521-531. doi: 10.1007/s10552-023-01679-x. Epub 2023 Mar 8.
10
Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018.2000年至2018年美国肾细胞癌患者的特定病因死亡率。
Urol Oncol. 2023 Apr;41(4):209.e11-209.e20. doi: 10.1016/j.urolonc.2023.01.024. Epub 2023 Feb 22.

引用本文的文献

1
Health Literacy, Individual and Community Engagement, and Cardiovascular Risks and Disparities: State-of-the-Art Review.健康素养、个体与社区参与以及心血管风险与差异:最新综述
JACC CardioOncol. 2024 May 7;6(3):363-380. doi: 10.1016/j.jaccao.2024.03.010. eCollection 2024 Jun.
2
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study.膀胱癌患者非肿瘤慢性药物治疗的特征及其对无复发生存率和癌症特异性生存率的影响:一项前瞻性研究。
J Clin Med. 2023 Oct 25;12(21):6749. doi: 10.3390/jcm12216749.

本文引用的文献

1
Duration of diabetes mellitus and risk of kidney and bladder cancer: a longitudinal nationwide cohort study.糖尿病病程与肾癌和膀胱癌风险:一项全国性纵向队列研究
Am J Cancer Res. 2022 Aug 15;12(8):4050-4061. eCollection 2022.
2
Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study.膀胱癌患者的心血管疾病死亡风险:一项基于人群的研究。
J Cardiovasc Dev Dis. 2022 Aug 9;9(8):255. doi: 10.3390/jcdd9080255.
3
Cause of death of patients with non-muscular invasive, non-metastatic muscular invasive and metastatic bladder cancer after diagnosis.
非肌层浸润性、非转移性肌层浸润性和转移性膀胱癌患者诊断后的死亡原因
Am J Transl Res. 2022 May 15;14(5):3494-3515. eCollection 2022.
4
Incidence and Risk Factors for Cerebrovascular-Specific Mortality in Patients with Colorectal Cancer: A Registry-Based Cohort Study Involving 563,298 Patients.结直肠癌患者脑血管特异性死亡率的发病率及危险因素:一项基于登记的队列研究,涉及563298例患者。
Cancers (Basel). 2022 Apr 19;14(9):2053. doi: 10.3390/cancers14092053.
5
Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis.二甲双胍对2型糖尿病膀胱癌患者发病率和肿瘤学结局的影响:一项更新的荟萃分析
Front Pharmacol. 2022 Apr 7;13:865988. doi: 10.3389/fphar.2022.865988. eCollection 2022.
6
Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance.糖尿病和酒精滥用与癌症的关联:分子机制和临床意义。
Cells. 2021 Nov 8;10(11):3077. doi: 10.3390/cells10113077.
7
Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients.根治性膀胱切除术、放疗和化疗对膀胱癌患者长期心脏特异性死亡风险的影响。
Transl Androl Urol. 2021 Oct;10(10):3826-3836. doi: 10.21037/tau-21-835.
8
Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.糖尿病和肥胖症作为膀胱癌预后的危险因素:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 7;12:699732. doi: 10.3389/fendo.2021.699732. eCollection 2021.
9
Survival Impact of Current-Smoking-Related COPD or COPD with Acute Exacerbation on Bladder Preservation through Concurrent Chemoradiotherapy for Muscle-Invasive Bladder Urothelial Carcinoma.当前吸烟相关慢性阻塞性肺疾病(COPD)或伴有急性加重的COPD对肌层浸润性膀胱尿路上皮癌同步放化疗保膀胱的生存影响。
J Pers Med. 2021 Sep 26;11(10):958. doi: 10.3390/jpm11100958.
10
The Sirenic Links between Diabetes, Obesity, and Bladder Cancer.糖尿病、肥胖症与膀胱癌之间的人鱼关联。
Int J Mol Sci. 2021 Oct 15;22(20):11150. doi: 10.3390/ijms222011150.